Frank Buttgereit

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 36

Top Topics

Rheumatoid Arthritis

Bone Mineral Density

Top Venues

Annals of the rheumatic diseases

Nature reviews. Rheumatology

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Buttgereit, Andriko Palmowski, Milena Bond, Giovanni Adami, Christian Dejaco
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nature reviews. Rheumatology (2024)
Frank Buttgereit, Andriko Palmowski, Milena Bond, Giovanni Adami, Christian Dejaco
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nature reviews. Rheumatology 20 (7) (2024)
Sandra Hermann, Andriko Palmowski, Kay-Geert A Hermann, Burkhard Muche, Nadége Léprêtre, Alexander Tobias, Zhivana Boyadzhieva, Gerhard Krönke, Paula Hoff, Edgar Wiebe, Frank Buttgereit
Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study. Rheumatology international (2024)
Andriko Palmowski, Maarten Boers, John R Kirwan, Robin Christensen, Frank Buttgereit
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis. Annals of internal medicine 177 (4) (2024)
Andriko Palmowski, Sabrina Mai Nielsen, Zhivana Boyadzhieva, Linda Hartman, Judith Oldenkott, Björn Svensson, Ingiäld Hafström, Siegfried Wassenberg, Ernest H S Choy, John R Kirwan, Robin Christensen, Maarten Boers, Frank Buttgereit
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis: Individual Patient Data From Five Randomized Trials. Annals of internal medicine (2023)
Tazio Maleitzke, Edgar Wiebe, Dörte Huscher, Cornelia M Spies, Jinwen Tu, Timo Gaber, Yu Zheng, Frank Buttgereit, Markus J Seibel, Hong Zhou
Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis. Arthritis research & therapy 25 (1) (2023)
Andriko Palmowski, Mitsuteru Akahoshi, Burkhard Muche, Zhivana Boyadzhieva, Sandra Hermann, Chikashi C Terao, Edgar Wiebe, Frank Buttgereit
No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses. Rheumatology international (2023)
Alessia Alunno, Tadej Avcin, Catherine Haines, Josef S Smolen, Francisca Sivera, Sara Badreh, Xenofon Baraliakos, Johannes W J Bijlsma, Frank Buttgereit, Kaushik Chaudhuri, José António Pereira Da Silva, Jean Dudler, Ricardo Jorge de Oliveira Ferreira, Tania Gudu, Eric Hachulla, Mette Holland-Fischer, AnnaMaria Iagnocco, Tue Wenzel Kragstrup, György Nagy, Vasco C Romão, Simon R Stones, Marloes van Onna, Christopher J Edwards
Points to consider: EULAR-UEMS standards for the training of European rheumatologists. Annals of the rheumatic diseases (2023)
Christian Dejaco, Andreas Kerschbaumer, Daniel Aletaha, Milena Bond, Elvis Hysa, Dario Camellino, Lisa Ehlers, Andy Abril, Simone Appenzeller, Maria Cinta Cid, Bhaskar Dasgupta, Christina Duftner, Peter C Grayson, Bernhard Hellmich, Alojzija Hocevar, Tanaz A Kermani, Eric L Matteson, Susan P Mollan, Lorna Neill, Cristina Ponte, Carlo Salvarani, Sebastian Eduardo Sattui, Wolfgang Andreas Schmidt, Philip Seo, Josef S Smolen, Jens Thiel, Carlos Enrique Toro Gutiérrez, Madeline Whitlock, Frank Buttgereit
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica. Annals of the rheumatic diseases (2023)
Laura Kim, Claudia Kedor, Frank Buttgereit, Harald Heidecke, Desiree Schaumburg, Carmen Scheibenbogen
Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS. Journal of clinical medicine 12 (15) (2023)
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger R Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco, Frank Buttgereit
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Annals of the rheumatic diseases (2022)
Frank Buttgereit, Andriko Palmowski, Idil Esen, Elisabeth Brouwer
TOCILIZUMAB IN GIANT CELL ARTERITIS: BETTER UNDERSTANDING THE BENEFITS. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Roswitha Dietzel, Sabine Wiegmann, Diana Borucki, Christian Detzer, Kim Nikola Zeiner, Désirée Schaumburg, Bjoern Bühring, Frank Buttgereit, Gabriele Armbrecht
Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition. RMD open 8 (2) (2022)
Andriko Palmowski, Edgar Wiebe, Burkhard Muche, Sandra Hermann, Christian Dejaco, Eric L Matteson, Frank Buttgereit
Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort. Cells 11 (3) (2022)
Josef S Smolen, Robert B M Landewe, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimmie L Hyrich, Janet E Pope, Savia de Souza, Tanja Alexandra Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd-Rüdiger R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, AnnaMaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Thea P M Vliet Vlieland, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the rheumatic diseases (2022)
Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka-Sienkiewicz, Su Chen, Yang Yang, Dilek Arikan, Ronilda D'Cunha, Yinuo Pang, Hartmut Kupper, Timothy Radstake, Howard Amital
Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody Drug Conjugate, in Adults with Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy: a Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase 2a Trial. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Timo Gaber, Frank Buttgereit
A new perspective is needed for positive selection of germinal center B cells with higher-affinity B cell receptors. Cellular & molecular immunology 19 (2) (2022)
Charlotte Hua, Frank Buttgereit, Bernard G Combe
Glucocorticoids in rheumatoid arthritis: current status and future studies. RMD open 6 (1) (2021)
Claudia Kedor, Jacqueline Detert, Rolf Rau, Siegfried Wassenberg, Joachim Listing, Pascal Klaus, Tanja Braun, Walter Hermann, Stefan Markus Weiner, Frank Buttgereit, Gerd-Rüdiger R Burmester
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands: results of the OA-TREAT study-a randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. RMD open 7 (2) (2021)
Moritz Pfeiffenberger, Alexandra Damerau, Igor Ponomarev, Christian H Bucher, Yuling Chen, Dirk Barnewitz, Christa Thöne-Reineke, Paula Hoff, Frank Buttgereit, Timo Gaber, Annemarie Lang
Functional Scaffold-Free Bone Equivalents Induce Osteogenic and Angiogenic Processes in a Human In Vitro Fracture Hematoma Model. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 36 (6) (2021)
Christian Dejaco, Johannes W J Bijlsma, Frank Buttgereit
Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha et al. Annals of the rheumatic diseases 80 (10) (2021)
Dario Camellino, Eric L Matteson, Frank Buttgereit, Christian Dejaco
Reply to: What could a new disease activity score for polymyalgia rheumatica do better? Nature reviews. Rheumatology 17 (3) (2021)
Bernhard Hellmich, Frank Buttgereit
GCA management guidelines - vive la différence? Nature reviews. Rheumatology 17 (11) (2021)
Rosa Ventura, Peter T Daley-Yates, Irene Mazzoni, Katia Collomp, Martial Saugy, Frank Buttgereit, Olivier Rabin, Mark Stuart
A novel approach to improve detection of glucocorticoid doping in sport with new guidance for physicians prescribing for athletes. British journal of sports medicine (2021)
Frank Buttgereit, Timo Gaber
New insights into the fascinating world of glucocorticoids: the dexamethasone-miR-342-Rictor axis in regulatory T cells. Cellular & molecular immunology 18 (3) (2021)
Frank Buttgereit
Glucocorticoids: surprising new findings on their mechanisms of actions. Annals of the rheumatic diseases 80 (2) (2020)
Dario Camellino, Eric L Matteson, Frank Buttgereit, Christian Dejaco
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Nature reviews. Rheumatology 16 (9) (2020)
Christian Dejaco, Alessia Alunno, Johannes W J Bijlsma, Annelies Boonen, Bernard G Combe, Axel Finckh, Pedro M Machado, Ivan Padjen, Francisca Sivera, Tanja Alexandra Stamm, Frank Buttgereit
Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Annals of the rheumatic diseases (2020)
Frank Buttgereit
Views on glucocorticoid therapy in rheumatology: the age of convergence. Nature reviews. Rheumatology 16 (4) (2020)
Christine March, Dörte Huscher, Emelina Preis, Alexander Makowka, Jakob Hoeppner, Frank Buttgereit, Gabriela Riemekasten, Kristina Norman, Elise Siegert
Response to the Letter to the Editor: Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis. Archives of rheumatology 35 (3) (2020)
Sara Monti, Ana Filipa Águeda, Raashid Ahmed Luqmani, Frank Buttgereit, Maria Cid, Christian Dejaco, Alfred Mahr, Cristina Ponte, Carlo Salvarani, Wolfgang Schmidt, Bernhard Hellmich
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis. RMD open 5 (2) (2019)
Frank Buttgereit, Vibeke Strand, Eun Bong Lee, Abraham Simon-Campos, Dorothy McCabe, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study. RMD open 5 (1) (2019)
Ana Filipa Águeda, Sara Monti, Raashid Ahmed Luqmani, Frank Buttgereit, Maria Cid, Bhaskar Dasgupta, Christian Dejaco, Alfred Mahr, Cristina Ponte, Carlo Salvarani, Wolfgang Schmidt, Bernhard Hellmich
Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis. RMD open 5 (2) (2019)